Literature DB >> 3512838

The role of K antigens as virulence factors in Klebsiella.

A M Simoons-Smit, A M Verweij-van Vught, D M MacLaren.   

Abstract

The importance of K antigen of Klebsiella as a virulence factor was studied in nine pairs of K+ and K- strains, each pair isogenic apart from the presence of K antigen. Loss of K antigen by nine K+ strains resulted in the reduced virulence of their K- variants in a mouse-skin model. This reduced virulence of K- strains for mice may be explained in all strains by a higher degree of phagocytosis as measured by chemiluminescence response of human polymorphonuclear leukocytes (PMNL) and in most strains by enhanced killing by either human PMNL or human serum or both. Although the protective role of the K antigen in serum-induced killing and killing by PMNL was generally evident, our results also suggested that other virulence factors were sometimes involved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512838     DOI: 10.1099/00222615-21-2-133

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  53 in total

1.  Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Authors:  V J Benedí; B Ciurana; J M Tomás
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).

Authors:  Y Arakawa; M Ohta; R Wacharotayankun; M Mori; N Kido; H Ito; T Komatsu; T Sugiyama; N Kato
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Morphological evidence for penetration of anti-O antibody through the capsule of Klebsiella pneumoniae.

Authors:  Y Meno; K Amako
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

4.  Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Authors:  D K Pomakova; C-B Hsiao; J M Beanan; R Olson; U MacDonald; Y Keynan; T A Russo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-15       Impact factor: 3.267

5.  Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae.

Authors:  Frank R Deleo; Liang Chen; Stephen F Porcella; Craig A Martens; Scott D Kobayashi; Adeline R Porter; Kalyan D Chavda; Michael R Jacobs; Barun Mathema; Randall J Olsen; Robert A Bonomo; James M Musser; Barry N Kreiswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

6.  O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Authors:  M Trautmann; M Ruhnke; T Rukavina; T K Held; A S Cross; R Marre; C Whitfield
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

7.  Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.

Authors:  I Ofek; K Kabha; A Athamna; G Frankel; D J Wozniak; D L Hasty; D E Ohman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae.

Authors:  H Sahly; H Aucken; V J Benedi; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; D Sandvang; J M Tomás; U Ullmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-02       Impact factor: 3.267

9.  Contribution of capsular and lipopolysaccharide antigens to the pathogenesis of Klebsiella pneumoniae respiratory tract infection.

Authors:  S Chhibber; S Aggarwal; V Yadav
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

10.  Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ.

Authors:  R Wacharotayankun; Y Arakawa; M Ohta; K Tanaka; T Akashi; M Mori; N Kato
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.